Émilie Charton

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial

Guillaume Eberst, Amélie Anota, Arnaud Scherpereel et al. · Clinical Cancer Research · 2019 · 23 citations

Medicine, Oncology, Pharmacotherapy +12

Unmet supportive care needs of caregivers according to medical settings of cancer patients: a cross-sectional study

Véronique Christophe, Amélie Anota, Laurence Vanlemmens et al. · Supportive Care in Cancer · 2022 · 22 citations

Medicine, Oncology, Oncology Nursing +17

Switch from abiraterone plus prednisone to abiraterone plus dexamethasone at asymptomatic PSA progression in patients with metastatic castration‐resistant prostate cancer

Charlotte Fenioux, Christophe Louvet, Émilie Charton et al. · British Journal of Urology · 2018 · 21 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study

Émilie Charton, Capucine Baldini, Yohan Fayet et al. · ESMO Open · 2023 · 19 citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study

C. Baldini, Émilie Charton, Émilien Schultz et al. · ESMO Open · 2022 · 16 citations · Full text

Medicine, Geriatric Medicine, Oncology +12